Reframing endometriosis Endometriosis has traditionally been described as a chronic gynaecological condition characterised by the presence of endometrial-like tissue outside the uterus.¹ Its most recognised symptoms include dysmenorrhoea, chronic pelvic …
-
-
Medical purpose, MiGeL and price discipline From 1 July 2026, Switzerland will introduce reimbursement for selected medical-purpose digital health applications through MiGeL/LiMA. This article explains how companies should approach Swiss …
-
Price Follows the Patient Pathway Healthcare companies often begin their pricing story in the wrong place. They start with the product. They describe the device, the assay, the implant, the …
-
News
France 2026; Why Reimbursement Route Selection Is Now the Strategic Risk for MedTech, IVD, Digital Health and AI Companies
Why choosing the wrong French pathway can damage evidence, pricing, adoption and investor confidence France is one of Europe’s most attractive markets for medtech, diagnostics, digital health and AI. It …
-
In healthcare, evidence only creates value when it answers the question the payer, HTA body, commissioner, hospital, regulator or investor is actually asking. Many healthtech companies do not fail because …
-
Product-market fit gets attention. Evidence-market fit gets reimbursement, procurement and scale. Regulatory approval may open the door. Evidence-market fit determines whether health systems will pay, procure, recommend or scale. Many …
-
News
NICE, DHSC and NHS England Digital Care Evidence Standards 2026: What HealthTech Companies Must Now Prove
Odelle Intelligence Briefing UK Digital Health, Adult Social Care, Health Economics and Reimbursement Strategy Odelle Technology has reviewed the 2026 direction of travel from NICE, the Department of Health and …
-
News
New Procedure, Old Payment Box: Why the 2026/27 NHS HRG Freeze Matters and How Surgical Innovators Can Work the System
A medtech company arrives in the NHS with what appears to be a breakthrough. The procedure is less invasive. The device is clever. Recovery may be faster. The surgeon can …
-
News
WHY YOU NEED TO THINK before using AI: A Framework for Preserving Critical Thinking in the Age of Artificial Intelligence
Overview Recent research demonstrates a critical insight that should reshape how individuals and organisations approach artificial intelligence: the timing, context, and intentionality behind AI use fundamentally determine whether these tools …
-
Indirect Treatment Comparisons in France: Why HAS Exposes the Limits of Multi-Market Evidence Strategies For over a decade, market access teams have observed a persistent pattern: indirect treatment comparisons (ITCs) …